When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Herpes simplex virus infection

Última revisão das evidências: 20 Oct 2026
Última atualização do tópico: 17 Nov 2026
17 Nov 2026

FDA approves pritelivir to treat mucocutaneous lesions caused by HSV infection

The Food and Drug Administration (FDA) has approved the antiviral drug pritelivir for immunocompromised adults who have mucocutaneous lesions caused by herpes simplex virus (HSV) infection and who have not responded to other therapies (acyclovir, valacyclovir, or famciclovir). Pritelivir is a first-in-class, oral HSV helicase-primase inhibitor that is active against both HSV-1 and HSV-2.

The approval follows the completion of a phase 3 randomized controlled trial which evaluated the efficacy of pritelivir in immunocompromised participants with mucocutaneous HSV infection who did not respond to other antivirals.[66]​​​ While results of the study are yet to be published, according to the FDA, 63% of patients receiving pritelivir had all lesions completely healed by 28 days compared with 34% of patients receiving either acyclovir, valacyiclovir, or famciclovir. The most common adverse effect was headache.

Pritelivir is expected to be available in the US by the end of 2026. It has not been approved in other countries as yet and is not recommended by any current major guidelines.

Ver Tratamento: novidades

Fonte original da atualização

Resumo

Definição

History and exam

Key diagnostic factors

  • dysuria (in women)
  • lymphadenopathy
  • genital ulcer
  • oral ulcer
  • fever
Full details

Other diagnostic factors

  • tingling sensation
  • headache/aseptic meningitis
Full details

Risk factors

  • HIV infection (risk factor for clinical disease)
  • use of immunosuppressive drugs (risk factor for clinical disease)
  • female sex (risk factor for seropositivity)
  • black race (risk factor for seropositivity)
  • increasing age (risk factor for seropositivity)
  • high-risk sexual behavior (risk factor for seropositivity)
  • lack of condom use (risk factor for seropositivity)
Full details

Diagnostic tests

1st tests to order

  • HSV polymerase chain reaction (PCR)
  • viral culture
Full details

Tests to consider

  • Glycoprotein G-based type-specific serology (gG1 and gG2)
Full details

Treatment algorithm

ACUTE

CNS involvement: encephalitis or meningitis

disseminated visceral involvement: esophagitis, pneumonitis, or hepatitis

genital disease: first episode, immunocompetent, nonpregnant

genital disease: first episode, immunocompromised, nonpregnant

genital disease: recurrent episode, immunocompetent, nonpregnant

genital disease: recurrent episode, immunocompromised, nonpregnant

genital disease: primary or first-episode, pregnant

genital disease: recurrent episode, pregnant

oral disease: first episode, immunocompetent

oral disease: first episode, immunocompromised

oral disease: recurrent episode, immunocompetent

oral disease: recurrent episode, immunocompromised

ONGOING

genital disease: sexually active or frequent severe recurrences, immunocompetent, nonpregnant

genital disease: sexually active or frequent severe recurrences, immunocompromised, nonpregnant

genital disease: pregnant

oral disease: frequent severe recurrences, immunocompetent

oral disease: frequent severe recurrences, immunocompromised

Contributors

Authors

Benjamin D. Lorenz, MD

Assistant Professor

Division of Hospital Medicine

MedStar Georgetown University Hospital

Washington, DC

利益声明

BDL declares that he has no competing interests. Since completing the 2024 review, BDL has become an employee of Moderna and has resigned as a contributor.

鸣谢

Dr Benjamin D. Lorenz would like to gratefully acknowledge Dr Christine Johnson and Dr Anna Wald, previous contributors to this topic.

利益声明

CJ reports funding from AiCuris; grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies; and royalties from Up To Date. AW reports grants from Agenus, Gilead, Genocea, Sanofi, and Vical to conduct clinical research studies. AW receives royalties from Up To Date. AW is an NIH grant recipient (NIH AI30731 and AI071113) and a consultant for Aicuris, Eisai, and Amgen.

同行评议者

Giuseppe Pizzo, DDS

Associate Professor

Department of Surgical, Oncological and Oral Sciences

School of Dentistry

University of Palermo

Palermo

Italy

利益声明

GP declares that he has no competing interests.

Paul Adamson, MD, MPH

Assistant Clinical Professor of Medicine

David Geffen School of Medicine

University of California, Los Angeles

Los Angeles, CA

利益声明

PA declares that he has no competing interests.

Nicholas Van Wagoner, MD, PhD

Associate Professor of Medicine

University of Alabama

Birmingham, AL

利益声明

NVW declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Centers for Disease Control and Prevention. Morbidity and mortality weekly report: sexually transmitted infections treatment guidelines, 2021. Jul 2021 [internet publication].全文

Patel R, Kennedy OJ, Clarke E, et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS. 2017 Dec;28(14):1366-79.全文  摘要

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 220: management of genital herpes in pregnancy. May 2020 [internet publication].全文

British Association for Sexual Health & HIV; Royal College of Obstetricians and Gynaecologists. Management of genital herpes in pregnancy. Oct 2014 [internet publication].全文

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Herpes simplex virus infection images
  • 鉴别诊断

    • Syphilis
    • Chancroid
    • Lymphogranuloma venereum
    更多 鉴别诊断
  • 指南

    • Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
    • Sexually transmitted infections treatment guidelines, 2021​​​​​
    更多 指南
  • 患者教育信息

    Cold sores

    Genital herpes

    更多 患者教育信息
  • padlock-locked登录或订阅即可浏览 BMJ Best Practice 临床实践完整内容

内容使用需遵循免责声明